financetom
Business
financetom
/
Business
/
Jones Soda Reports Fourth Quarter And Full Year 2023 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jones Soda Reports Fourth Quarter And Full Year 2023 Results
Mar 14, 2024 1:45 PM

04:16 PM EDT, 03/14/2024 (MT Newswires) -- Jones Soda Co. ( JSDA ) , a beverage company focused on developing, marketing and distributing consumer drink and wellness products and is in the cannabis-infused beverage category space, announced Thursday its financial results for the fourth quarter and full year ending Dec. 31, 2023.

The company reported in the Fourth Quarter 2023 Financial Summary versus a year ago that revenue was $3.5 million compared to $3.7 million.

The fourth quarter of 2023 included approximately $438,000 in revenue from the company's Mary Jones cannabis business compared to approximately $239,000 in Q4 2022.

"During the fourth quarter, we experienced headwinds in our foodservice and grocery channels from a revenue perspective and our gross margins were negatively impacted by a one-time inventory write-off, which led to less-than-ideal top-line financial results to close out the year, however, I believe we continued to make progress towards positioning Jones Soda ( JSDA ) for exciting long-term growth opportunities," said David Knight, President and CEO of Jones Soda ( JSDA ), in a statement.

For the full Year 2023 Financial Summary compared to the prior year, revenue was $16.7 million compared to $19.1 million.

Full year 2023 included approximately $1.2 million in revenue from the company's Mary Jones cannabis business compared to approximately $353,000 in 2022.

Price: 0.2497, Change: +0.0148, Percent Change: +6.3006

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
May 26, 2025
Elanco Animal Health Incorporated ( ELAN ) on Monday announced the sale of certain future tiered royalties and commercial milestones associated with Xdemvy (lotilaner ophthalmic solution) 0.25% for the human health application of lotilaner to Blackstone Life Sciences and Blackstone Credit & Insurance for $295 million in cash. The company will use the proceeds to accelerate debt reduction, positioning Elanco to achieve an expected...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BRIEF-Blank Check Company Stonebridge Acquisition Ii Corp - Files For $50 Million IPO - SEC Filing
BRIEF-Blank Check Company Stonebridge Acquisition Ii Corp - Files For $50 Million IPO - SEC Filing
May 26, 2025
* BLANK CHECK COMPANY STONEBRIDGE ACQUISITION II CORP - FILES FOR $50 MILLION IPO - SEC FILING * STONEBRIDGE ACQUISITION II CORP: MAXIM GROUP LLC IS UNDERWRITER TO IPO- SEC FILING * STONEBRIDGE ACQUISITION II CORP: INTEND TO APPLY TO HAVE UNITS LISTED ON NASDAQ UNDER SYMBOL APACU Source text: Further company coverage: [ ] ...
BRIEF-Castle Biosciences To Acquire Previse
BRIEF-Castle Biosciences To Acquire Previse
May 26, 2025
Castle Biosciences Inc ( CSTL ): * CASTLE BIOSCIENCES TO ACQUIRE PREVISE * CASTLE BIOSCIENCES INC ( CSTL ): TERMS OF AGREEMENT ARE UNDISCLOSED. Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved